Array BioPharma To Present At The Leerink Swann Global Healthcare Conference
BOULDER, Colo., Feb. 5, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Swann Healthcare Conference in New York. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
| Event: |
Leerink Swann Healthcare Conference |
| Presenter: |
Ron Squarer, Chief Executive Officer |
| Date: |
Wednesday, February 11, 2015 |
| Time: |
10:15 a.m. Eastern Time |
| Location: |
The Waldorf Astoria, New York, NY |
| Webcast: |
|
| http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-EventDetails&EventId=5184603 |
|
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently enrolling patients. These programs include two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis). For more information on Array, please go to www.arraybiopharma.com
| CONTACT: |
Tricia Haugeto |
| Array BioPharma Inc. |
|
| 303-386-1193 |
|
Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
SOURCE Array BioPharma Inc.
Share this article